News Briefs

07/01/2022

American Regent, Provepharm Life Solutions intro ProvayBlue injection

Image
generic vial teaser

American Regent and Provepharm Life Solutions are offering ProvayBlue (methylene blue) injection in a 10 ml single-dose vial.

ProvayBlue is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.

The new vial presentation joins the ampule that American Regent and Provepharm Life Solutions have been marketing since 2016. 

Provepharm has licensed exclusive rights to American Regent to market and distribute ProvayBlue in the United States.

We are pleased that our continued partnership with Provepharm provides the opportunity to expand our line of ProvayBlue products to better meet the needs of providers and patients, said Joann Gioia, vice president and chief commercial officer at American Regent.

Advertisement
06/28/2022

LifeStyles refreshes packaging across entire portfolio

Image
lifestyles teaser

LifeStyles is debuting a fresh, brand-new look.

The sexual wellness company unveiled its new packaging redesign, which features a sleek and modern look that was inspired by the brand’s fresh new chapter in its legacy, LifeStyles said.

“LifeStyles has a 100-plus year history exclusively dedicated to sexual wellness. We take immense pride in being a reliable resource that enables greater connections for all,” said M’lou Walker, CEO of LifeStyles Healthcare.

“When customers see our products, we want them to be as excited to grab them off the shelf as we are to make them,” Walker said. “Our revitalized design was crafted to inspire shoppers instantly to explore more fulfilling sexual experiences with confidence and comfort.”

By recognizing the evolving attitudes of today’s consumers, the brand revamped its identity to connect more deeply with users at shelf, the company said.

LifeStyles offers a range of products including condoms, lubricants and accessories that can be found at such retailers as Walmart, Walgreens and Rite Aid among others.

06/27/2022

Walgreens offering Independence Day discount to veterans, active duty military

Image
a building with a store on the side of a road

To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a weekend Independence Day discount to all veterans, active-duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country.

Beginning July 1 through July 4, customers with a myWalgreens membership and valid military ID or proof of service will receive 20% off regularly priced products at any Walgreens or Duane Reade drugstore nationwide.

The myWalgreens customer loyalty platform membership is free and can be obtained at checkout, the company said. 

Walgreens stores will be open during regular business hours on Independence Day. For patient needs, 24-hour Walgreens pharmacies will be open, and select non-24-hour pharmacies will be open with modified hours.

Advertisement
06/27/2022

Hilco debuts Kool-Aid Sour Belts

Image
kool-aid sour belt teaser

Hilco is continuing its partnership for the fourth consecutive year with Kraft Heinz, with the launch of a new line of Kool-Aid brand candy.

The latest from the Louisville, Ky.-based company are Kool-Aid Sour Belts, which come in four flavors — tropical punch, cherry, grape and strawberry kiwi.

Featuring a dusted flat licorice-like texture, the candy is suitable for all ages and comes in a 3.5-oz. bag that retails for $1.99.

06/24/2022

NACDS Total Store Expo to feature Axios’ Jonathan Swan

Image
jonathan swan teaser

The National Association of Chain Drug Stores announced that Jonathan Swan, national political reporter at Axios, will speak at the NACDS Political Involvement Reception during the NACDS Total Store Expo 2022, taking place from Aug. 27 to 29 in Boston.

Swan is regarded as one of the best-sourced reporters covering both political parties in Washington, D.C., and one of the most groundbreaking interviewers on American television, NACDS said.

Swan serves as the lead reporter on the “Axios on HBO” show, during which he has interviewed global leaders — including Ukraine President Volodymyr Zelensky, NATO Secretary General Jens Stoltenberg, director general of the World Trade Organization Ngozi Okonjo-Iweala, Iraq President Barham Salih and Prime Minister of Pakistan Imran Khan — as well as influential democratic and republican leaders in the United States, such as Sen. Bernie Sanders (I-Vt.) and Sen. Mitch McConnell (R-Ky).

[Read more: NACDS to host listening sessions prior to White House conference on hunger, nutrition, health]

Swan’s 2020 “Axios on HBO” interview with President Trump — which was seen and shared by more than 100 million people — earned him an Emmy Award and the 2022 Aldo Beckman Award for Overall Excellence in White House Coverage.

“Jonathan Swan has distinguished himself as one of the most preeminent, political storytellers of our time, and we look forward to the unique insights he will offer on the current political environment, as we rapidly approach Election Day,” said NACDS president and CEO Steve Anderson. “Jonathan will bring tremendous value to the signature NACDS-PAC event during the NACDS Total Store Expo.”

The bipartisan NACDS-PAC supports congressional candidates who understand and help to advance pro-pharmacy and pro-patient policies. The event is open to NACDS-PAC contributors and invited guests.

[Read more: NACDS, 93 groups urge continued access to pandemic-related services at pharmacies]

NACDS urges member company representatives to register now for the fast-approaching 2022 NACDS Total Store Expo.

06/23/2022

Amber Specialty Pharmacy expands Evusheld services

Image
generic vial teaser

Amber Specialty Pharmacy, a Hy-Vee subsidiary, is offering expanded Evusheld services.

The Food and Drug Administration has issued an emergency use authorization for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) for the pre-exposure prophylaxis of COVID-19 in adults and pediatric individuals age 12 years old and older weighing at least 40 kg.

Evusheld may be prescribed for individuals who are not currently infected with SARS-CoV-2, who have not had a known recent exposure to an individual infected with SARS-CoV-2 and who are moderate to severe immune compromised due to a medical condition or receipt of immunosuppressive medications or treatments and may not mount an adequate immune response to COVID-19 vaccination or for whom vaccination with any available COVID-19 vaccine, according to the approved or authorized schedule, which is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s).

This can include transplant recipients, as well as oncology and other immunocompromised patients. Amber Specialty Pharmacy’s high-touch service model is designed to support prescribers, like transplant programs, oncologists and others, who may have patients who might be prescribed Evusheld. The pharmacy provides comprehensive services beginning at the moment of referral, through delivery and beyond, to ensure the best possible patient outcomes, the company said.

“Throughout the pandemic, Amber Specialty Pharmacy has consistently risen to the occasion to take care of our patients. Through the administration of monoclonal antibodies, we kept our focus on delivering solutions when our patients needed them the most,” said Kristin Williams, president of Amber Specialty Pharmacy. “Our expanded Evusheld services represent our continued commitment to caring for our patients, especially those who have been without therapeutic options that provided adequate immune response.”

Amber Specialty Pharmacy will offer Evusheld at its 19 locations throughout the United States. They also coordinate delivery and nursing for at-home administration, if needed, the company said.